-
1دورية أكاديمية
لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل. -
2دورية أكاديمية
المؤلفون: Robbins DW; Nurix Therapeutics, Inc., 1700 Owens St., San Francisco, California 94158, United States., Noviski MA; Nurix Therapeutics, Inc., 1700 Owens St., San Francisco, California 94158, United States., Tan YS; Nurix Therapeutics, Inc., 1700 Owens St., San Francisco, California 94158, United States., Konst ZA; Nurix Therapeutics, Inc., 1700 Owens St., San Francisco, California 94158, United States., Kelly A; Nurix Therapeutics, Inc., 1700 Owens St., San Francisco, California 94158, United States., Auger P; Nurix Therapeutics, Inc., 1700 Owens St., San Francisco, California 94158, United States., Brathaban N; Nurix Therapeutics, Inc., 1700 Owens St., San Francisco, California 94158, United States., Cass R; Nurix Therapeutics, Inc., 1700 Owens St., San Francisco, California 94158, United States., Chan ML; Nurix Therapeutics, Inc., 1700 Owens St., San Francisco, California 94158, United States., Cherala G; Nurix Therapeutics, Inc., 1700 Owens St., San Francisco, California 94158, United States., Clifton MC; Nurix Therapeutics, Inc., 1700 Owens St., San Francisco, California 94158, United States., Gajewski S; Nurix Therapeutics, Inc., 1700 Owens St., San Francisco, California 94158, United States., Ingallinera TG; Nurix Therapeutics, Inc., 1700 Owens St., San Francisco, California 94158, United States., Karr D; Nurix Therapeutics, Inc., 1700 Owens St., San Francisco, California 94158, United States., Kato D; Nurix Therapeutics, Inc., 1700 Owens St., San Francisco, California 94158, United States., Ma J; Nurix Therapeutics, Inc., 1700 Owens St., San Francisco, California 94158, United States., McKinnell J; Nurix Therapeutics, Inc., 1700 Owens St., San Francisco, California 94158, United States., McIntosh J; Nurix Therapeutics, Inc., 1700 Owens St., San Francisco, California 94158, United States., Mihalic J; Nurix Therapeutics, Inc., 1700 Owens St., San Francisco, California 94158, United States., Murphy B; Nurix Therapeutics, Inc., 1700 Owens St., San Francisco, California 94158, United States., Panga JR; Nurix Therapeutics, Inc., 1700 Owens St., San Francisco, California 94158, United States., Peng G; Nurix Therapeutics, Inc., 1700 Owens St., San Francisco, California 94158, United States., Powers J; Nurix Therapeutics, Inc., 1700 Owens St., San Francisco, California 94158, United States., Perez L; Nurix Therapeutics, Inc., 1700 Owens St., San Francisco, California 94158, United States., Rountree R; Nurix Therapeutics, Inc., 1700 Owens St., San Francisco, California 94158, United States., Tenn-McClellan A; Nurix Therapeutics, Inc., 1700 Owens St., San Francisco, California 94158, United States., Sands AT; Nurix Therapeutics, Inc., 1700 Owens St., San Francisco, California 94158, United States., Weiss DR; Nurix Therapeutics, Inc., 1700 Owens St., San Francisco, California 94158, United States., Wu J; Nurix Therapeutics, Inc., 1700 Owens St., San Francisco, California 94158, United States., Ye J; Nurix Therapeutics, Inc., 1700 Owens St., San Francisco, California 94158, United States., Guiducci C; Nurix Therapeutics, Inc., 1700 Owens St., San Francisco, California 94158, United States., Hansen G; Nurix Therapeutics, Inc., 1700 Owens St., San Francisco, California 94158, United States., Cohen F; Nurix Therapeutics, Inc., 1700 Owens St., San Francisco, California 94158, United States.
المصدر: Journal of medicinal chemistry [J Med Chem] 2024 Feb 22; Vol. 67 (4), pp. 2321-2336. Date of Electronic Publication: 2024 Feb 01.
نوع المنشور: Journal Article
بيانات الدورية: Publisher: American Chemical Society Country of Publication: United States NLM ID: 9716531 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1520-4804 (Electronic) Linking ISSN: 00222623 NLM ISO Abbreviation: J Med Chem Subsets: MEDLINE
-
3دورية أكاديمية
المؤلفون: Ong TIW; Department of Medicine, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia., Lim LL; Department of Medicine, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia., Chan SP; Department of Medicine, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia.; Subang Jaya Medical Centre, Subang Jaya, Selangor, Malaysia., Chee WSS; International Medical University, Kuala Lumpur, Malaysia., Ch'ng ASH; Hospital Seberang Jaya, Pulau Pinang, Malaysia., Chong EGM; Hospital Kuala Lumpur, Kuala Lumpur, Malaysia., Damodaran P; Pantai Hospital Kuala Lumpur, Kuala Lumpur, Malaysia., Hew FL; Subang Jaya Medical Centre, Subang Jaya, Selangor, Malaysia., Ibrahim LB; Regency Specialist Hospital, Johor Bahru, Johor, Malaysia., Khor HM; Department of Medicine, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia., Lai PSM; Department of Primary Care Medicine, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia., Lee JK; Beacon Hospital, Petaling Jaya, Selangor, Malaysia., Lim AL; Hospital Pulau Pinang, Pulau Pinang, Malaysia., Lim BP; Subang Jaya Medical Centre, Subang Jaya, Selangor, Malaysia., Paramasivam SS; Department of Medicine, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia., Ratnasingam J; Department of Medicine, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia., Siow YS; Subang Jaya Medical Centre, Subang Jaya, Selangor, Malaysia., Tan ATB; Sunway Medical Centre, Petaling Jaya, Selangor, Malaysia., Thiagarajan N; Klinik Kesihatan Kuala Lumpur, Kuala Lumpur, Malaysia., Yeap SS; Subang Jaya Medical Centre, Subang Jaya, Selangor, Malaysia.
المصدر: Osteoporosis and sarcopenia [Osteoporos Sarcopenia] 2023 Jun; Vol. 9 (2), pp. 60-69. Date of Electronic Publication: 2023 Jun 20.
نوع المنشور: Journal Article; Review
بيانات الدورية: Publisher: The Korean Society of Osteoporosis ; production and hosting by Elsevier B.V Country of Publication: Netherlands NLM ID: 101666399 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2405-5263 (Electronic) Linking ISSN: 24055255 NLM ISO Abbreviation: Osteoporos Sarcopenia Subsets: PubMed not MEDLINE
-
4دورية أكاديمية
المؤلفون: Zhang D; Laboratory of Lymphoid Malignancies, Hematology Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD., Harris HM; Laboratory of Lymphoid Malignancies, Hematology Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD., Chen J; Laboratory of Lymphoid Malignancies, Hematology Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD., Judy J; Bioinformatics Core, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD., James G; Laboratory of Lymphoid Malignancies, Hematology Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD., Kelly A; Nurix Therapeutics, Inc, San Francisco, CA., McIntosh J; Nurix Therapeutics, Inc, San Francisco, CA., Tenn-McClellan A; Nurix Therapeutics, Inc, San Francisco, CA., Ambing E; Nurix Therapeutics, Inc, San Francisco, CA., Tan YS; Nurix Therapeutics, Inc, San Francisco, CA., Lu H; Nurix Therapeutics, Inc, San Francisco, CA., Gajewski S; Nurix Therapeutics, Inc, San Francisco, CA., Clifton MC; Nurix Therapeutics, Inc, San Francisco, CA., Yung S; Nurix Therapeutics, Inc, San Francisco, CA., Robbins DW; Nurix Therapeutics, Inc, San Francisco, CA., Pirooznia M; Bioinformatics Core, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD., Skånland SS; Laboratory of Lymphoid Malignancies, Hematology Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD.; Department of Cancer Immunology, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway.; K. G. Jebsen Centre for B Cell Malignancies, Institute of Clinical Medicine, University of Oslo, Oslo, Norway., Gaglione E; Laboratory of Lymphoid Malignancies, Hematology Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD., Mhibik M; Laboratory of Lymphoid Malignancies, Hematology Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD., Underbayev C; Laboratory of Lymphoid Malignancies, Hematology Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD., Ahn IE; Laboratory of Lymphoid Malignancies, Hematology Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD., Sun C; Laboratory of Lymphoid Malignancies, Hematology Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD., Herman SEM; Laboratory of Lymphoid Malignancies, Hematology Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD., Noviski M; Nurix Therapeutics, Inc, San Francisco, CA., Wiestner A; Laboratory of Lymphoid Malignancies, Hematology Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD.
المصدر: Blood [Blood] 2023 Mar 30; Vol. 141 (13), pp. 1584-1596.
نوع المنشور: Journal Article
بيانات الدورية: Publisher: Elsevier Country of Publication: United States NLM ID: 7603509 Publication Model: Print Cited Medium: Internet ISSN: 1528-0020 (Electronic) Linking ISSN: 00064971 NLM ISO Abbreviation: Blood Subsets: MEDLINE
مواضيع طبية MeSH: Leukemia, Lymphocytic, Chronic, B-Cell*/drug therapy , Leukemia, Lymphocytic, Chronic, B-Cell*/genetics , Leukemia, Lymphocytic, Chronic, B-Cell*/metabolism, Humans ; Agammaglobulinaemia Tyrosine Kinase ; Heterografts ; Drug Resistance, Neoplasm ; Protein Kinase Inhibitors/pharmacology ; Protein Kinase Inhibitors/therapeutic use ; Pyrimidines/therapeutic use
-
5دورية أكاديمية
المؤلفون: Yeap SS; Department of Medicine, Subang Jaya Medical Centre, Subang Jaya, Selangor, Malaysia., Nur Fazirah MFR; Faculty of Medicine and Health Sciences, Universiti Putra Malaysia, Serdang, Selangor, Malaysia., Nur Aisyah C; Faculty of Medicine and Health Sciences, Universiti Putra Malaysia, Serdang, Selangor, Malaysia., Zahari Sham SY; Department of Pathology, Faculty of Medicine and Health Sciences, Universiti Putra Malaysia, Serdang, Malaysia., Samsudin IN; Department of Pathology, Faculty of Medicine and Health Sciences, Universiti Putra Malaysia, Serdang, Malaysia., C Thambiah S; Department of Pathology, Faculty of Medicine and Health Sciences, Universiti Putra Malaysia, Serdang, Malaysia., Hew FL; Department of Medicine, Subang Jaya Medical Centre, Subang Jaya, Selangor, Malaysia., Lim BP; Department of Orthopaedic Surgery, Subang Jaya Medical Centre, Subang Jaya, Selangor, Malaysia., Siow YS; Department of Orthopaedic Surgery, Subang Jaya Medical Centre, Subang Jaya, Selangor, Malaysia., Chan SP; Department of Medicine, Subang Jaya Medical Centre, Subang Jaya, Selangor, Malaysia.
المصدر: Osteoporosis and sarcopenia [Osteoporos Sarcopenia] 2017 Jun; Vol. 3 (2), pp. 112-116. Date of Electronic Publication: 2017 Jun 03.
نوع المنشور: Journal Article
بيانات الدورية: Publisher: The Korean Society of Osteoporosis ; production and hosting by Elsevier B.V Country of Publication: Netherlands NLM ID: 101666399 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2405-5263 (Electronic) Linking ISSN: 24055255 NLM ISO Abbreviation: Osteoporos Sarcopenia Subsets: PubMed not MEDLINE
-
6دورية أكاديمية
المؤلفون: Zhu Y; Cell and Molecular Biology Program and Breast Cancer and the Environment Research Program, Michigan State University, East Lansing, MI, USA., Aupperlee MD; Department of Physiology and Breast Cancer and the Environment Research Program, Michigan State University, East Lansing, MI, USA., Zhao Y; Department of Physiology and Breast Cancer and the Environment Research Program, Michigan State University, East Lansing, MI, USA., Tan YS; Department of Physiology and Breast Cancer and the Environment Research Program, Michigan State University, East Lansing, MI, USA., Kirk EL; Department of Epidemiology, University of North Carolina at Chapel Hill, NC, USA., Sun X; Department of Epidemiology, University of North Carolina at Chapel Hill, NC, USA., Troester MA; Department of Epidemiology, University of North Carolina at Chapel Hill, NC, USA.; Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, NC, USA.; Department of Pathology and Laboratory Medicine, University of North Carolina at Chapel Hill, NC, USA., Schwartz RC; Department of Microbiology and Molecular Genetics and Breast Cancer and the Environment Research Program, Michigan State University, East Lansing, MI, USA., Haslam SZ; Department of Physiology and Breast Cancer and the Environment Research Program, Michigan State University, East Lansing, MI, USA.
المصدر: Oncotarget [Oncotarget] 2016 Dec 13; Vol. 7 (50), pp. 83409-83423.
نوع المنشور: Comparative Study; Journal Article
بيانات الدورية: Publisher: Impact Journals Country of Publication: United States NLM ID: 101532965 Publication Model: Print Cited Medium: Internet ISSN: 1949-2553 (Electronic) Linking ISSN: 19492553 NLM ISO Abbreviation: Oncotarget Subsets: MEDLINE
مواضيع طبية MeSH: Carcinoma/*etiology , Cell Transformation, Neoplastic/*metabolism , Diet, High-Fat/*adverse effects , Mammary Glands, Animal/*metabolism , Mammary Neoplasms, Experimental/*etiology , Tumor Suppressor Protein p53/*deficiency, Age Factors ; Animals ; Apoptosis ; Carcinoma/genetics ; Carcinoma/metabolism ; Carcinoma/pathology ; Cell Proliferation ; Cell Transformation, Neoplastic/genetics ; Cell Transformation, Neoplastic/pathology ; Female ; Gene Expression Regulation, Neoplastic ; Genetic Predisposition to Disease ; Macrophages/metabolism ; Macrophages/pathology ; Mammary Glands, Animal/pathology ; Mammary Neoplasms, Experimental/genetics ; Mammary Neoplasms, Experimental/metabolism ; Mammary Neoplasms, Experimental/pathology ; Mice, Inbred BALB C ; Mice, Knockout ; Neovascularization, Pathologic ; Phenotype ; Risk Factors ; Sexual Development ; Time Factors ; Tumor Suppressor Protein p53/genetics
-
7دورية أكاديمية
المؤلفون: Ozaki M; Center for Experimental Therapeutics and Reperfusion Injury, Department of Anesthesiology, Perioperative and Pain Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA; Department of Emergency and Critical Care Medicine, St. Marianna University School of Medicine, Kawasaki, Japan., Kang Y; Center for Experimental Therapeutics and Reperfusion Injury, Department of Anesthesiology, Perioperative and Pain Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA., Tan YS; Center for Experimental Therapeutics and Reperfusion Injury, Department of Anesthesiology, Perioperative and Pain Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA., Pavlov VI; Center for Experimental Therapeutics and Reperfusion Injury, Department of Anesthesiology, Perioperative and Pain Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA., Liu B; Department of Pediatrics, Cardiovascular Thrombosis Laboratory, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA., Boyle DC; Department of Pediatrics, Cardiovascular Thrombosis Laboratory, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA., Kushak RI; Department of Pediatrics, Cardiovascular Thrombosis Laboratory, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA., Skjoedt MO; Center for Experimental Therapeutics and Reperfusion Injury, Department of Anesthesiology, Perioperative and Pain Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA; Department of Clinical Immunology and Tissue Typing Lab, University Hospital of Copenhagen, Rigshospitalet, Denmark., Grabowski EF; Department of Pediatrics, Cardiovascular Thrombosis Laboratory, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA., Taira Y; Department of Emergency and Critical Care Medicine, St. Marianna University School of Medicine, Kawasaki, Japan., Stahl GL; Center for Experimental Therapeutics and Reperfusion Injury, Department of Anesthesiology, Perioperative and Pain Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA. Electronic address: gstahl@partners.org.
المصدر: Kidney international [Kidney Int] 2016 Oct; Vol. 90 (4), pp. 774-82. Date of Electronic Publication: 2016 Jul 01.
نوع المنشور: Journal Article
بيانات الدورية: Publisher: Elsevier Country of Publication: United States NLM ID: 0323470 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1523-1755 (Electronic) Linking ISSN: 00852538 NLM ISO Abbreviation: Kidney Int Subsets: MEDLINE
مواضيع طبية MeSH: Antibodies, Monoclonal/*therapeutic use , Complement C3d/*metabolism , Escherichia coli Infections/*drug therapy , Hemolytic-Uremic Syndrome/*drug therapy , Immunoglobulin G/*therapeutic use , Mannose-Binding Lectin/*immunology , Shiga Toxin 2/*toxicity, Animals ; Antibodies, Monoclonal, Murine-Derived ; Complement Activation/drug effects ; Disease Models, Animal ; Escherichia coli Infections/blood ; Escherichia coli Infections/immunology ; Escherichia coli Infections/microbiology ; Gene Knock-In Techniques ; Glomerular Filtration Rate ; Hemolytic-Uremic Syndrome/blood ; Hemolytic-Uremic Syndrome/immunology ; Hemolytic-Uremic Syndrome/microbiology ; Humans ; Immunohistochemistry ; Kidney/immunology ; Male ; Mannose-Binding Lectin/genetics ; Mice ; Mice, Inbred C57BL ; Mice, Knockout ; Shiga Toxin 2/immunology ; Shiga-Toxigenic Escherichia coli/metabolism
-
8دورية أكاديمية
المؤلفون: Aupperlee MD; Breast Cancer and the Environment Research Program, Department of Physiology, Michigan State University, Biomedical and Physical Sciences Building, Room 2201, 567 Wilson Road, East Lansing, MI, 48824, USA. aupperl4@msu.edu., Zhao Y; Breast Cancer and the Environment Research Program, Department of Physiology, Michigan State University, Biomedical and Physical Sciences Building, Room 2201, 567 Wilson Road, East Lansing, MI, 48824, USA. yzhao818@hotmail.com.; Present address: College of Chemistry and Pharmaceutical Sciences, Qingdao Agricultural University, Qingdao, 266109, People's Republic of China. yzhao818@hotmail.com., Tan YS; Breast Cancer and the Environment Research Program, Department of Physiology, Michigan State University, Biomedical and Physical Sciences Building, Room 2201, 567 Wilson Road, East Lansing, MI, 48824, USA. yingsiow@gmail.com.; Present address: Novartis Institutes for BioMedical Research, 250 Massachusetts Avenue, Cambridge, MA, 02139, USA. yingsiow@gmail.com., Zhu Y; Breast Cancer and the Environment Research Program, Department of Physiology, Michigan State University, Biomedical and Physical Sciences Building, Room 2201, 567 Wilson Road, East Lansing, MI, 48824, USA. zhuyiron@msu.edu., Langohr IM; Department of Pathobiology and Diagnostic Investigation, Michigan State University, East Lansing, MI, USA. langohr@msu.edu.; Present address: Department of Pathobiological Sciences, School of Veterinary Medicine, Louisiana State University, Baton Rouge, LA, 70803, USA. langohr@msu.edu., Kirk EL; Department of Pathology and Laboratory Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA. ekirk@email.unc.edu., Pirone JR; Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA. jrpirone@gmail.com., Troester MA; Department of Pathology and Laboratory Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA. troester@unc.edu.; Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA. troester@unc.edu.; Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA. troester@unc.edu., Schwartz RC; Breast Cancer and the Environment Research Program, Department of Microbiology and Molecular Genetics, Michigan State University, Biomedical and Physical Sciences Building, Room 2201, 567 Wilson Road, East Lansing, MI, 48824, USA. schwart9@msu.edu., Haslam SZ; Breast Cancer and the Environment Research Program, Department of Physiology, Michigan State University, Biomedical and Physical Sciences Building, Room 2201, 567 Wilson Road, East Lansing, MI, 48824, USA. shaslam@msu.edu.
المصدر: Breast cancer research : BCR [Breast Cancer Res] 2015 Nov 02; Vol. 17 (1), pp. 138. Date of Electronic Publication: 2015 Nov 02.
نوع المنشور: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
بيانات الدورية: Publisher: BioMed Central Ltd Country of Publication: England NLM ID: 100927353 Publication Model: Electronic Cited Medium: Internet ISSN: 1465-542X (Electronic) Linking ISSN: 14655411 NLM ISO Abbreviation: Breast Cancer Res Subsets: MEDLINE
مواضيع طبية MeSH: Carcinogenesis/*metabolism , Carcinoma, Adenosquamous/*etiology , Diet, High-Fat/*adverse effects , Mammary Neoplasms, Experimental/*etiology, Animals ; Carcinoma, Adenosquamous/metabolism ; Chemokines/metabolism ; Female ; Mammary Glands, Animal/growth & development ; Mammary Glands, Animal/metabolism ; Mammary Glands, Animal/pathology ; Mammary Neoplasms, Experimental/metabolism ; Mice, Inbred BALB C ; Sexual Maturation ; Transcriptome ; beta Catenin/metabolism
-
9دورية أكاديمية
المؤلفون: Aupperlee MD; Breast Cancer and the Environment Research Program, Departments of Physiology (M.D.A., Y.Z., Y.S.T., J.R.L., J.B., S.Z.H.) and Microbiology and Molecular Genetics (R.C.S.), Michigan State University, East Lansing, Michigan 48824., Zhao Y, Tan YS, Leipprandt JR, Bennett J, Haslam SZ, Schwartz RC
المصدر: Endocrinology [Endocrinology] 2014 Jun; Vol. 155 (6), pp. 2301-13. Date of Electronic Publication: 2014 Apr 02.
نوع المنشور: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
بيانات الدورية: Publisher: Oxford University Press Country of Publication: United States NLM ID: 0375040 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1945-7170 (Electronic) Linking ISSN: 00137227 NLM ISO Abbreviation: Endocrinology Subsets: MEDLINE
مواضيع طبية MeSH: ErbB Receptors/*metabolism , Estrogens/*pharmacology , Leukocytes/*cytology , Mammary Glands, Animal/*drug effects , Mammary Glands, Animal/*metabolism , Progesterone/*pharmacology, Acid Phosphatase/pharmacology ; Animals ; ErbB Receptors/genetics ; Female ; Fluorescent Antibody Technique ; Isoenzymes/pharmacology ; Mice ; Mice, Inbred BALB C ; Reverse Transcriptase Polymerase Chain Reaction ; Signal Transduction/drug effects ; Tartrate-Resistant Acid Phosphatase
-
10دورية أكاديمية
المؤلفون: Zhao Y, Tan YS, Aupperlee MD, Langohr IM, Kirk EL, Troester MA, Schwartz RC, Haslam SZ
المصدر: Breast cancer research : BCR [Breast Cancer Res] 2013; Vol. 15 (5), pp. R100.
نوع المنشور: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
بيانات الدورية: Publisher: BioMed Central Ltd Country of Publication: England NLM ID: 100927353 Publication Model: Print Cited Medium: Internet ISSN: 1465-542X (Electronic) Linking ISSN: 14655411 NLM ISO Abbreviation: Breast Cancer Res Subsets: MEDLINE
مواضيع طبية MeSH: Diet, High-Fat* , Sexual Maturation*, Breast Neoplasms/*etiology , Mammary Neoplasms, Experimental/*etiology, Animals ; Breast Neoplasms/metabolism ; Breast Neoplasms/mortality ; Breast Neoplasms/pathology ; Cell Proliferation ; Cytokines/metabolism ; Female ; Gene Expression Profiling ; Hormones/blood ; Humans ; Inflammation/genetics ; Inflammation/metabolism ; Inflammation Mediators/metabolism ; Intercellular Signaling Peptides and Proteins/genetics ; Intercellular Signaling Peptides and Proteins/metabolism ; Mammary Neoplasms, Experimental/metabolism ; Mammary Neoplasms, Experimental/mortality ; Mammary Neoplasms, Experimental/pathology ; Mice ; Neovascularization, Pathologic/genetics ; Neovascularization, Pathologic/metabolism ; Signal Transduction ; Time Factors ; Tumor Microenvironment